用于口咽癌研究的自动化AJCC重新分期工具
针对AJCC第8版将HPV阳性口咽鳞状细胞癌(OPSCC)单独分期导致第7版与第8版病例无法直接比较的问题,研究者开发了从第7版向第8版自动重分期的计算工具。该工具在机构数据集上准确率100%(95%CI 98.8%-100%,成功重分期326/326例),在美国国家癌症数据库上准确率93.4%(95%CI 93.1%-93.7%,成功重分期26,505/28,374例)。
要点
- 工具可自动将HPV阳性OPSCC的病理与临床分期从AJCC第7版转换为第8版。
- 机构数据集重分期准确率100%(95%CI 98.8%-100%),326/326例成功。
- 国家癌症数据库重分期准确率93.4%(95%CI 93.1%-93.7%),26,505/28,374例成功。
核心结论
- 该开源计算工具可实现HPV阳性OPSCC从AJCC第7版到第8版的自动重分期,有助于未来HPV阳性OPSCC研究,并可启发针对其他癌种及后续AJCC版本的类似工具。
研究设计与样本
- 开发并验证一种自动化计算工具,用于将HPV阳性OPSCC的病理与临床肿瘤分期从AJCC第7版重新分类为第8版,并在机构数据集与美国国家癌症数据库数据集上进行验证。
主要发现
- 在机构数据集上,算法准确率为100%(95%CI 98.8%-100%),成功重分期326/326例。
- 在美国国家癌症数据库数据集上,算法准确率为93.4%(95%CI 93.1%-93.7%),成功重分期26,505/28,374例。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With the American Joint Committee on Cancer (AJCC) 8th edition staging guidelines update, human papillomavirus-positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC) is now staged separately from its HPV-negative counterpart, preventing meaningful comparison of cases staged with the 7th versus 8th edition criteria. Manual restaging is time-consuming and error-prone, hindering multiyear analyses for HPV+ OPSCC. We developed an automated computational tool for re-classifying HPV+ OPSCC pathological and clinical tumor staging from AJCC 7th to 8th edition. The tool is designed to handle large data sets, ensuring comprehensive and accurate analysis of historic HPV+ OPSCC data. Validated against institutional and National Cancer Database data sets, the algorithm achieved accuracies of 100% (95% confidence interval [CI] 98.8%-100%) and 93.4% (95% CI 93.1%-93.7%), successfully restaging 326/326 and 26,505/28,374 cases, respectively. With its open-source design, this computational tool can enhance future HPV+ OPSCC research and inspire similar tools for other cancer types and subsequent AJCC editions.
引用
- Safranek CW, Wilkins SG, Shah R, et al. Automated AJCC Restaging for Oropharyngeal Cancer Research. Otolaryngol Head Neck Surg. 2023. PMID: 37855637. doi:10.1002/ohn.558
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。